chrisvoncsefalvay/vaers-outcomes huggingface dataset:
intense dizziness; lightheadedness; made her feel like she was going to pass out.; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 15Aug2021 (Lot number: FC3181) at the age of 61 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS POSTURAL (non-serious) with onset 15Aug2021, outcome "unknown", described as "intense dizziness"; DIZZINESS (non-serious) with onset 15Aug2021, outcome "unknown", described as "lightheadedness"; PRESYNCOPE (non-serious) with onset 15Aug2021, outcome "unknown", described as "made her feel like she was going to pass out.".  Additional information : Patient described about 30-45 minutes after vaccine she bent down to pick something up then walked to her garage and had intense dizziness and lightheadedness that made her feel like she was going to pass out. Denies any previous heart issues, dizziness spells, or vaccination reactions.  No follow-up attempts are possible. No further information is expected.
Severe pain "stabbing all over my body with knives"; Fever 102; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Severe pain "stabbing all over my body with knives") and PYREXIA (Fever 102) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced PAIN (Severe pain "stabbing all over my body with knives") and PYREXIA (Fever 102). At the time of the report, PAIN (Severe pain "stabbing all over my body with knives") and PYREXIA (Fever 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Apr-2021, Body temperature: 102 (High) High 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient stated she waited 3 months after having COVID-19 to receive the vaccine. She is not willing to go for the second dose. Event treatment: Tylenol (acetaminophen).
3 wks after FLU vaccine, developed backache, diarrhea, chills, drank lots of fluid, temp 104.2, nausea, tired & sleepy. Four other members of family had flu-like symptoms at same time.
Patient experinced tightness in chest, shoulder pain, and felt as if she were going to pass out.
August 20 2021- Woke up with moderate -severe numbness/tingling/pins and needles along upper/lower left arm with same symptoms left hand extending to 4th and 5th fingers. (felt like "it was asleep).   (I want to stress that there was no numbness or tingling whatsoever the day before I woke up with symptoms)  Had slight swelling in feet and lower legs as well.  Foot swelling lasted about 2 weeks.  Saw Dr at clinic  to rule out cardiac/and infection.  There was no further swelling in feet, however left lower arm (left hand.4th and 5th fingers still remain numb and tingling, but not as severe as the time. Saw orthopedic Dr to evaluate 9/17/21 at 2:30.  Was asked to set up EMG and nerve conduction test and had done on 9/30/21
No additional AE reported; Tem excursion of 47.9 F for 47 min on Dec. 1st 2022/ VAQTA administered after a temperature excursion.; This spontaneous report was received from a medical assistant and refers to a 2-year-old male patient.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 22-DEC-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, lot number W017343 was verified as valid, expiration date reported and upon internal review established as 13-DEC-2023, administered intramuscularly in the left thigh for prophylaxis (strength was not provided) after a temperature excursion that happened on 01-DEC-2022 at a temperature of 47.9 Fahrenheit degree for 47 minutes (product storage error). No additional adverse event reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2301USA009943:MSD
Narrative: Patient received zoster vaccine on 11/10/21 in PCP office. Patient called clinic 2 days later complaining of swelling at the injection site. Patient was counseled by nurse that such reactions are normal and should abate in 48-72 hours. Patient had no further concerns per accessible documentation.
Sciaitic nerve is acting up and wants to take ibuprofen to help.; This spontaneous report from a contactable consumer via Pfizer-sponsored program.   A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on an unspecified date as 1st dose, single for covid-19 immunisation.The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced Sciatica nerve was acting up and wants to take ibuprofen to help on an unspecified date. Patient clarified has not taken ibuprofen or anything for nerve pain and has been many years since Sciatica nerve has acted up. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
17 years of age, were inadvertently administered the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age, were inadvertently administered the Moderna COVID-19 vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age, were inadvertently administered the Moderna COVID-19 vaccine). On 03-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age, were inadvertently administered the Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications reported. no treatment details reported.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL (dose, route and lot# not reported). On an unspecified date the patient was diagnosed with cervical cancer. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. Upon internal review, cervical cancer was considered to be an other important medical event. No further information is available.
Swollen lymph nodes in neck, swollen itching injection site. Symptoms started within 24 hours of vaccine administration. Physician instructed patient to take cetirizine and ranitidine.
administer expired vaccine to patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  It was reported that vials had not undergone any temperature excursion. Total of 102 doses/vials were given for LOT  026C21A.  Date the vial was initially stored in the refrigerator was reported as unknown.  No treatment medication were reported   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live Follow up document contain non-significant information: primary reporter address
This spontaneous report as received from Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. Since 17-OCT-2014 the patients were vaccinated with an improperly stored dose of RECOMBIVAX HB (strength, route of administration, dose and lot # were not reported). The vaccine was exposed to a supported temperature excursion on 17-OCT-2014. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Case previously recorded as MA2009-4844. Initial case report received from a pharmacist via Novartis on 24 NOV 2009. A 58-year-old male patient was vaccinated with FLUVIRIN (batch no. 101716P1A) i.m. on 21 NOV 2009. The patient experienced dizziness following the shot flu and blood pressure slightly increased. The patient had recovered on 21 NOV 2009. MedCom reference no.: NA09-008751.
pt was pale, staring into space-not breathing approx 630PM; 28FEB95 mom shook pt-gave mouth to mouth; brought to ER via ambulance-tx; observed & sent home p/24 hrs;
inflammatory reaction in the areas of prior JUVEDERM VOLUMA XC injections three days after second Pfizer vaccination; This is a spontaneous report received from a contactable other healthcare professional. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation; and hyaluronic acid, lidocaine (JUVEDERM VOLUMA XC, formulation: injection, route of administration, start and stop date, batch/lot number and dose were not reported) for an unspecified indication. The patient medical history and concomitant medications were not reported. Reportedly, the reporter was consulting on a case of a patient who had an inflammatory reaction in the areas of prior JUVEDERM VOLUMA XC injections on an unspecified date (three days after second Pfizer vaccination). Patient was given 5mg of lisinopril (as therapeutic measures for inflammatory reaction), an ACE inhibitor, with 80 % resolution overnight and complete resolution the day after second dose. The action taken in response to the event(s) for hyaluronic acid was unknown. Outcome of event was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Approx 1 hr after DTP started to convulse, turned blue and temp to 104+ taken to clinic and treated with 2X dose of tylenol and sponge baths. Temp held taken to hospital treated in I/C 3hrs retained in hosp overnight. Temp rose again 103.
This spontaneous report was received from a physician concerning a female patient in her early twenties who on 06-JUL-2012 was vaccinated with the first dose of GARDASIL (dose, route and lot # not provided). The physician reported that the patient experienced shortness of breath and cough within hours of receiving the first dose of GARDASIL on 06-JUL-2012. The patient received treatment with cough suppressants (unspecified) and an inhaler (unspecified) for the cough and shortness of breath. No laboratory tests were performed. On 09-JUL-2012, the patient visited the physician's office. At the time of the report, the patient had not recovered from the events. The relatedness for shortness of breath and cough was unknown for GARDASIL. Additional information has been requested.
For 24 hrs after receiving the bivalent booster, my arm was painfully sore and I had chills and joint/body aches and pains. These symptoms subsided for about 4-5 hrs, and then the evening of 10/7/2022 I started getting a stuffy nose, chest tightness, chills, and a fever of 100.4. On Saturday 10/8/2022 I woke up feeling flu-like symptoms. I took an at-home Covid test, and it was positive for Covid. So I somehow caught Covid either right before getting the booster shot or soon thereafter. My doctor prescribed Paxlovid, via a telehealth phone call, and I'm feeling much better now!
Raised hives on feet, legs, arms, abdomen lasting several hours to 1 day. Took 50mg Benadryl at night and hives were gone within 24 hours.
I have no intention of sounding like a crazy person but I am curious if there are any findings of the Covid vaccination in children causing seizures. my son had his first ever seizure at an abnormally older age (according to the neurologist) for febrile seizures just one week after his second dose. I didn't think anything of it until this weekend my friend?s 6 year old daughter also had her first seizure just a few weeks after her second vaccination. I don't know anyone with children at these older ages beginning seizures sand I let his pediatrician know. She suggested that I fill out this form.
After receiving Hepatitis A vaccine patient fainted and had some seizure activity, including eyes twitching, tonic-clonic movements of arms and legs and stiffening of his back. Was unresponsive for approximately 1 to 2 minutes with seizure-like activity less than 1 minute. Upon recovery was oriented to person, time, place. Knew President of the U.S. (even though he recently arrived from another country) and knew how many dimes in a dollar. Refused transport to hospital by EMTs who did attend to patient.
pt recv vax 17MAY96 10AM & t105, given APAP 330PM;sz @ 6PM; amb went to ER;no other sz reported
"Pins and Needles" and localize numbness on left shin to foot.  Identical symptoms were experienced in my right leg following the 2nd vaccination shot (COVID-19 Moderna on 5/14/21) but I had not attributed a relationship to the vaccine at that time.  The "Pins and Needles" and numbness slowly dissipated since the 2nd shot but has not entirely disappeared as of yet (very minor localized pins and needles)
Swelling of the eyes and mouth. Itchy ears.  Didn't have any trouble breathing. Took allergy meds.
BODY ACHES; LEG PAIN; HEADACHES; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lymph node cancer. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown expiry date: UNKNOWN) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-MAY-2021, the subject experienced body aches. On 26-MAY-2021, the subject experienced leg pain. On 26-MAY-2021, the subject experienced headaches. The action taken with covid-19 vaccine  was not applicable. The patient recovered from leg pain on 27-MAY-2021, and had not recovered from body aches, and headaches. This report was non-serious.
(Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Additional information added
She Had her first menstruation after the vaccine. She has not have other menstruation after that.
Cellulitis 7cmx10cm. Keflex 250/5ml 2 tsp BID x10 days.
Pt is a G1P0, recently diagnosed with gestational diabetes. Gestational age 30 weeks.  Intrauterine fetal demise occurred around 24-36 hours after vaccination.
About 20 to 25 minutes after shots, wife says patient became tired & listless. So that's about 5:45pm-5:50pm. Went to bed at 7:15pm because tired. He tossed & turned most of night. At 9-9:30am, took his temperature, it was 104 degrees F. Got appointment to urgent care at 2pm (on 9/2/12). Arm (left) very tender and swollen up to neck. Urgent care sent him to emergency where they admitted him to the hospital for 1 night. Temp was 102.4 degrees at urgent care and 100.4 F at hospital. Home now but temp fluctuates. WBC increased.
This spontaneous report as received from a nurse practitioner refers to an unspecified patient of unknown age and gender. No information on patient's medical history or concurrent conditions was provided. On an unknown date in 2012, the patient was vaccinated with the first dose, and on 18-AUG-2015, with the second dose of GARDASIL injection (dose, route of administration, lot# and expiration date were not provided for both). No information on patient's concomitant medications was provided. No adverse effects were reported. Additional information has been requested.
I experienced extreme headaches, neck and arm pain, nausea with pain in my stomach along with development of a rash. The headaches and nausea progressively became worst. I almost went to the walk-in-clinic but chose not to go. If I were not able to control the vomiting or had diarrhea, I would have gone to the ER. The symptoms resided on their own after a few days. I have an appointment to see my doctor on Friday to ensure that the symptoms are gone since I still have bouts of stomach cramping.
She began producing lots of mucus nasally.  This caused a cough.  No fever.  No lymphadenopathy.  It comes across as an allergic reaction to her second shot.
Fever 104 + within 12 hours of administration at 4 mo and 6 mo immunizations. Resulted in 2nd visit to clinic but no adverse outcome (see other side). Discussed risks of not immunizing greater then febrile illness controlled with antipyretics. Mother in agreement. Discussed likely exaggerated response to immunizations.
Information has been received from a retired pediatrician concerning his wife who "about four months ago" in approximately February 2007 was vaccinated with a dose of Zostavax (Oka/Merck).  It was noted that the reporter administered the vaccine.  On 15-JUN-2007 the patient developed shingles, the patient's symptoms were right sided upper quadrant facial pain.  Unspecified medical attention was sought.  The patient was taking VALTREX as treatment.  There was no product quality complaint involved.  No further information was provided.  Additional information has been requested.
This spontaneous report as received from a office manager (other health professional) refers to an unknown number of patients of unknown demographics. Pertinent medical histories, current condition, reactions and allergies were not reported. On an unknown date, the patient was vaccinated with VAQTA dosage regimen were not reported (lot # M0278879 expiry date: 24-JAN-2018). Concomitant medications were not reported. On an unknown date, the patients received an unknown number of doses VAQTA following temperature excursions of 47.5F for 30 minutes and 65.4 F for 17 hours 45 minutes and 43.34F for 10 minutes (incorrect product storage). No adverse effects (no adverse event) were reported in any patients. No further information is available. No Product quality complaint (PQC) was involved. Additional information is not expected as the reporter did not give us consent to contact physician. This is one of 3 reports received from same reporter. MARRS # 1611USA008585 and MARRS # 1611USA008534.
Patient called to say she experienced a very heavy nosebleed with large clots  at approx 8pm as she was lying down to sleep for the night. She stated she never experienced a nosebleed prior to this episode. It stopped after about 15 minutes. She is following up with her doctor. Otherwise she has had no other effects.
Patient given vaccine that expired 10/31/2022 on 12/2/2022
Breakthrough case admission after 2 Janssen Janssen 4/8/21 Lot# 042A21A; Janssen 12/13/21 Lot# 213D21A
Intense stomach cramps once or twice an hour, diarrhea, vomiting; treated with clear liquids, Pepto Bismol, prescription with anti-spasmatic
Painful, Itchy rash on back, armpit, breast and chest (all left side- Later diagnosed as Shingles). Swollen painful lymph node in left armpit.
Administered 2nd COVID-19 vaccine to patient 06/28/2021, 2 days past BUD. BUD for vaccination was 06/28/2021. Attempted to contact patient, unsure if patient called pharmacy back yesterday or today. Waiting to hear back from Moderna regarding efficacy of vaccination administered as well as proper follow-up with patient.
Developed vestibular neuritis and Labyrinthitis by a specialist ENT audiologist did a VNG test.  Loss of balance and dizziness . Did 9 weeks of vestibular rehabilitation therapy.  80% better but still have episodes of loss of balance
Hives, Pyrexia, Fever >100.0. Claritin was given PO upon onset. Ibruprofen 800 mg PO immediately.
Patient was ordered to receive a Meningococcal and a Gardasil 9 HPV Vaccine. The patient did receive the Gardasil 9 HPV Vaccine, however, instead of the Meningococcal vaccine the nurse inadvertently gave Tuberculin Purified Protein Derivative (Mantoux) Tubersol. Patient did not report any side effects at the time of administration.
I had vaccination on 09/16/2022. On 02/22/2023 I had a cough with congestion with runny nose and I could not sleep. The Doctor prescribed medication and I am still taking the antibiotics.
Tingling feeling in extremities and head, happening 3 days after and continuing to this date
Sudden allergy/intolerance to the protein in egg whites. Previously ate eggs 4-5x a week with no problem. No I can only eat hard boiled or baked as the high temps kill the proteins. If I eat scrambled or fried or other cooked eggs are lower/shorter temps I experience nausea, abdominal pain, diarrhea and vomiting.
received expired doses today 30Aug2021, The use-by date was 27Aug2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired doses today 30Aug2021, The use-by date was 27Aug2021) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired doses today 30Aug2021, The use-by date was 27Aug2021). On 30-Aug-2021, EXPIRED PRODUCT ADMINISTERED (received expired doses today 30Aug2021, The use-by date was 27Aug2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Pt had shot (flu) at 12:35 pm on 9/19/11. Pt said at sundown he got shaky, passed out had a temp 101 degrees, EMT came and monitor him for 45 mins.
pt recv 2 doses  of vax 5MAY95 & 2JUL95 & 10APR96 lab eval was negative for IgM & IgG;no further details were provided
Tinnitus. after fever and muscle aches. Tinnitus is continuing a month after vaccine (muscle aches etc. subsided 48 hrs after vaccine)